Cargando…

Supervised on-site dosing in injectable opioid agonist treatment-considering the patient perspective. Findings from a cross-sectional interview study in two German cities

BACKGROUND: Injectable opioid agonist treatment (iOAT) is an effective option to support people living with opioid use disorder (OUD) who have not sufficiently benefitted from oral OAT. However, iOAT has been criticised based on theoretical and practical grounds for its dosing policies: Current regu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Friedmann, Zoe, Kinkel, Hans-Tilmann, Kühner, Claudia, Zsolnai, Andreas, Mick, Inge, Binder, Annette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619267/ https://www.ncbi.nlm.nih.gov/pubmed/37915058 http://dx.doi.org/10.1186/s12954-023-00896-6

Ejemplares similares

New Approaches in Drug Dependence: Opioids
por: Mielau, Juliane, et al.
Publicado: (2021)

Importance of Opioid Agonist Therapy to Reduce Injection-Related Infections
por: Weaver, Victoria K, et al.
Publicado: (2022)

Breastfeeding on Injectable Opioid Agonist Therapy: A Case Report
por: Patricelli, Charissa J., et al.
Publicado: (2023)

Better agonist for the opioid receptors
por: Badshah, Syed Lal, et al.
Publicado: (2018)

Prevalence of Opioid Dependence and Opioid Agonist Treatment in the Berlin Custodial Setting: A Cross-Sectional Study
por: von Bernuth, Kira, et al.
Publicado: (2020)

Alcohol use in opioid agonist treatment
por: Nolan, Seonaid, et al.
Publicado: (2016)

Therapeutic Potential of Kappa Opioid Agonists
por: Beck, Tyler C., et al.
Publicado: (2019)

Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor
por: Li, Zoe, et al.
Publicado: (2023)

Interim opioid agonist treatment for opioid addiction: a systematic review
por: Samsó Jofra, Laura, et al.
Publicado: (2022)

Availability of opioid agonist treatment and critical incidents in Forensic Clinics for Dependency Diseases in Germany
por: Reiners, Sven, et al.
Publicado: (2022)

Impact of Ambient Ultrafine Particles on Cause-Specific Mortality in Three German Cities
por: Schwarz, Maximilian, et al.
Publicado: (2023)

Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes
por: Day, Nathaniel, et al.
Publicado: (2022)

Perinatal Injectable Opioid Agonist Therapy (iOAT) Administration: A Case Series
por: Patricelli, Charissa J., et al.
Publicado: (2023)

Sex work involvement among women with long-term opioid injection drug dependence who enter opioid agonist treatment
por: Marchand, Kirsten, et al.
Publicado: (2012)

A Deficit in Movement-Derived Sentences in German-Speaking Hearing-Impaired Children
por: Ruigendijk, Esther, et al.
Publicado: (2017)

Psychometric evaluation of the German version of the Brief Reflective Functioning Interview
por: Andreas, Sylke, et al.
Publicado: (2021)

Seroprevalence of Measles-, Mumps-, and Rubella-specific antibodies in the German adult population – cross-sectional analysis of the German Health Interview and Examination Survey for Adults (DEGS1)
por: Friedrich, Nicole, et al.
Publicado: (2021)

Evolutionary Game Research on Green Construction Considering Consumers’ Preference under Government Supervision
por: Geng, Xiaoxiao, et al.
Publicado: (2022)

The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.
por: Bharat, Chrianna, et al.
Publicado: (2022)

Changing Pattern of Opioid Users Attending an Opioid Agonist Treatment Clinic in North India
por: Bhat, Fazle R., et al.
Publicado: (2022)

What is the benefit of inconsistent opioid agonist treatment in patients with prescription opioid use disorder?
por: Weiss, R., et al.
Publicado: (2023)

Service delivery models for injectable opioid agonist treatment in Canada: 2 sequential environmental scans
por: Eydt, Erin, et al.
Publicado: (2021)

Full Opioid Agonists and Tramadol: Pharmacological and Clinical Considerations
por: Edinoff, Amber N., et al.
Publicado: (2021)

Novel Mixed NOP/Opioid Receptor Peptide Agonists
por: Pacifico, Salvatore, et al.
Publicado: (2021)

In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist - neurokinin 1 receptor antagonist chimera
por: Guillemyn, Karel, et al.
Publicado: (2012)

Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study
por: Larney, Sarah, et al.
Publicado: (2018)

Reliability and validity of the German version of the Structured Interview of Personality Organization (STIPO)
por: Doering, Stephan, et al.
Publicado: (2013)

Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors
por: Shen, Qianwei, et al.
Publicado: (2017)

Prevention, diagnosis, and treatment of opioid use disorder under the supervision of opioid stewardship programs: it’s time to act now
por: Kim, Eun-Ji, et al.
Publicado: (2022)

Supervised learning events in the Foundation Programme: a UK-wide narrative interview study
por: Rees, Charlotte E, et al.
Publicado: (2014)

Drug Quality Co-regulation Supervision Strategy Considering Collusion Behavior With New Media Participation
por: Zhang, Siyi, et al.
Publicado: (2022)

A Biopsychosocial Overview of the Opioid Crisis: Considering Nutrition and Gastrointestinal Health
por: Wiss, David A.
Publicado: (2019)

We Must Consider a Growing Opioid Epidemic in Older People
por: Hudson, Murray A J, et al.
Publicado: (2022)

Quantity and quality of conflict of interest policies at German medical schools: a cross-sectional study and survey
por: Grabitz, Peter, et al.
Publicado: (2020)

Acceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian City
por: Mitra, Sanjana, et al.
Publicado: (2017)

Biphalin—A Potent Opioid Agonist—As a Panacea for Opioid System-Dependent Pathophysiological Diseases? †
por: Redkiewicz, Patrycja, et al.
Publicado: (2021)

Opioid initiation and injection transition in rural northern New England: A mixed-methods approach
por: Nolte, Kerry, et al.
Publicado: (2020)

Trends in smoking during pregnancy stratified by the use of opioid agonist therapy and the contribution of smoking to poor outcome in neonates prenatally exposed to opioid agonist treatment
por: Kelty, Erin, et al.
Publicado: (2023)

The Art of Investigative Interviewing
por: Black, Inge
Publicado: (2013)

Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy
por: Janjua, Naveed Z., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c9a8t9j1k8o52uvd7mvom1b468